Universitätsklinikum Leipzig, Klinik und Poliklinik für Onkologie, Gastroenterologie, Hepatologie, Pneumologie und Infektiologie
Department: Not specified
ROR ID: Not specified
Web page: https://www.uniklinikum-leipzig.de/einrichtungen/medizinische-klinik-2/hepatologie
Country: 
Germany
City: Leipzig
Address: Not specified
Related items
https://orcid.org/0000-0003-0003-6241
For each clinical trial conducted according to the German Medicines Act (AMG) or the Medical Devices Act (MPG), a sponsor must be named who assumes overall responsibility for the clinical trial. In the case of human clinical trials initiated and managed by staff of the Medical Faculty of the University of Leipzig or Leipzig University Hospital (UKL) (Investigator Initiated Trials; IITs), the University of Leipzig assumes the function of sponsor if no third party is the sponsor.
Trial Projects:
- STOP-NUC: A multicentre randomized controlled trial evaluating the rate of sustained remission and the safety when stopping nucleos(t)ide analogue treatment in non-cirrhotic HBeAg-negative chronic Hepatitis B patients with long-term virologic response
- BASALIT: Birch Associated Soy Allergy and Immuno-Therapy
- ADIPO-Vent: Optimierung der perioperativen maschinellen Ventilation bei adipösen und normalgewichtigen Patienten durch PEEP-Titration anhand der Elektrischen Impedanz-Tomografie
- GRAFT: Granulocyte colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure
- AbCD: Antibody diagnostics in paediatric Coeliac Disease
- TIBICO: Effectiveness of TNI vs. BiPAP in Chronic Global Insufficiency in COPD Patients
- Test-MDS
Coordinating investigator: Prof. Dr. Florian van Bömmel Sektion Hepatologie, Klinik und Poliklinik für Gastroenterologie und Rheumatologie Universitätsklinikum Leipzig Sponsor: Universität Leipzig Ritterstr. 26, 04109 Leipzig Registration: EudraCT: 2013-004882-15 DRKS: DRKS00006240
Nucleos(t)ide analogues (NUCs) are the standard and mostly lifelong treatment for chronic HBeAg -negative hepatitis B, as functional cure (loss of HBsAg) is rarely achieved. Discontinuation of NUC treatment ...
Sponsor: Leipzig University (Sponsor)
Public web page: https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004882-15/DE
Start date: 18th Nov 2014
End date: 30th Jan 2022
Coordinating investigator: Prof. Dr. Thomas Berg Sektion Hepatologie, Klinik und Poliklinik für Gastroenterologie und Rheumatologie, Universitätsklinikum Leipzig
Sponsor: Universität Leipzig Ritterstr. 26, 04109 Leipzig
Registration: EudraCT: 2015-002212-32 ClinicalTrials.gov: NCT02669680
Sponsor: Leipzig University (Sponsor)
Public web page: https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002212-32/DE
Studienleitung: Prof. Dr. med. Hubert WirtzDr. med. Jens Bräunlich Universität Leipzig Department Innere Medizin, Neurologie und Dermatologie Abteilung für Pneumologie\ Registration: clinicaltrials.gov: NCT02007772
Sponsor: Leipzig University (Sponsor)
Public web page: https://clinicaltrials.gov/ct2/show/record/NCT02007772?term=NCT02007772
